Beijing, China

Le Yin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Beijing Jitai Life Sciences Ltd., Hangzhou Jitai Life Sciences Ltd, Metis Techbio Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Le Yin. Retrieved from https://idiyas.com/inventor/le-yin-38w87qpx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Le Yin - Innovator in Lipid Nanoparticle Technology

Introduction

Le Yin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of lipid nanoparticles. His innovative work focuses on enhancing the delivery of nucleic acids, which has important implications for medical treatments.

Latest Patents

Le Yin holds 1 patent related to lipid nanoparticles. The patent details a lipid nanoparticle wherein the lipid ingredient comprises a compound of formula (IV). This invention also includes a method for preparing the lipid nanoparticle, a pharmaceutical composition of the lipid nanoparticle, and its use in the delivery of nucleic acids.

Career Highlights

Throughout his career, Le Yin has worked with notable companies such as Beijing Jitai Life Sciences Ltd. and Hangzhou Jitai Life Sciences Ltd. His experience in these organizations has allowed him to refine his expertise in lipid nanoparticle technology and its applications in pharmaceuticals.

Collaborations

Le Yin has collaborated with talented individuals in his field, including Liu Yang and Andong Liu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Le Yin is a key figure in the innovation of lipid nanoparticles, with a focus on improving nucleic acid delivery systems. His work continues to influence the pharmaceutical industry and holds promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…